Adverse Event Management

Brain Cancer

Breast Cancer

Childhood/AYA Cancer

Disparities in Cancer Care

Drug Safety

Gastrointestinal Cancer

Genetics

Genitourinary Cancer

Gynecologic Cancers

Head and Neck Cancers

Hematology

Immuno-Oncology

Lung Cancer

Myeloproliferative Neoplasms

Nurse Navigation

Prevention

Radiation Oncology

Sarcomas

Skin Cancer/Melanoma

Supportive Care

Survivorship

Statistically and clinically meaningful improvements in invasive disease-free survival were observed among patients with hormone receptor–positive/HER2-negative early breast cancer who received ribociclib in addition to endocrine therapy.

Adding Ribociclib to Endocrine Therapy Yields 25% Relative Reduction in Risk of Invasive Disease In Patients With HR+/HER2– Early Breast Cancer

The 3 year-pelvic recurrence rates with simple hysterectomy were comparable with those of radical hysterectomy among patients with low-risk, early-stage cervical cancer.

Simple Hysterectomy May Replace Radical Hysterectomy as Standard of Care in Low-Risk, Early-Stage Cervical Cancer

Alyssa Ridad BSN-RN, OCN; and Amanda McKaig, BSN, RN, OCN, discuss oncology nurse perceptions of medical cannabis.

Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical Cannabis 

Pediatric patients with leukemia in low- and middle-income countries saw improvements in survival outcomes following implementation of the WHO Framework for Action model.

Improvements in Health Systems Model Reduces Disparities in Leukemia Survival in Low-Income Countries

News

FDA News

Latest News

Oncology Drug Crash Course

Media

Insights

Medical World News

Peer Exchange

Podcasts

Videos

Conferences

Conference Coverage

Conference Listing

Publications

CME/CE

Cancer Insight Summary Slides

Continuing Education

Resources

Contributors

Webinars

Subscribe

Partners

Articles

Ana Van Der Wall, MD reflects on her mother’s influence to become a medical oncologist

GCC’s Pharmacogenomics Program may help reduce side effects from chemotherapy for some patients

VCU Massey Cancer Center has been designated a Comprehensive Cancer Center by the National Cancer Institute (NCI), the nation’s principal authority on cancer research and training.

VCU Massey Cancer Center achieves comprehensive status from the National Cancer Institute

Patients with depression had a 37% higher risk of dying from their disease than patients without a mental health diagnosis.

Study suggests Lymphoma Patients With Depression or Anxiety Experience Shorter Survival Times

Oncology Drug Crash Course: Olaparib (Lynparza)

Latest Conference Coverage